Literature DB >> 4915447

Preliminary clinical evaluation of glybenclamide in treatment of diabetes mellitus.

B F Johnson, C K Bhatia, W J Rzeszotarski, F W Wolff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4915447     DOI： 10.2337/diab.19.8.579

Source DB:  PubMed          Journal:  Diabetes        ISSN： 0012-1797            Impact factor:   9.461


× No keyword cloud information.
  4 in total

1.  Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.

Authors:  P Berchtold; P Björntorp; A Gustafson; A Jonsson; S E Fagerberg
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

Review 2.  Glibenclamide: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 3.  Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?

Authors:  A Marble
Journal:  Drugs       Date:  1971       Impact factor: 9.546

4.  Synthetic protection short interfering RNA screen reveals glyburide as a novel radioprotector.

Authors:  Jianfei Jiang; Peter R McDonald; Tracy M Dixon; Darcy Franicola; Xichen Zhang; Suhua Nie; Laura D Epperly; Zhentai Huang; Valerian E Kagan; John S Lazo; Michael W Epperly; Joel S Greenberger
Journal:  Radiat Res       Date:  2009-10       Impact factor: 2.841
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.